Paediatric clinical pharmacist: a potential benefit?

Area of Science:

• Pediatric Pharmacology
• Medication Safety
• Clinical Pharmacy

Background:

• Medication errors in pediatric prescribing occur in 10-15% of cases, with incorrect drug dosing being the most common type.
• Pediatric patients exhibit maturational changes in pharmacokinetic and pharmacodynamic parameters, posing challenges for accurate drug prescribing.
• Neonatal and infant populations, as well as obese children, are particularly vulnerable to medication errors due to unique physiological considerations.

Purpose of the Study:

• To highlight the prevalence and nature of medication errors in pediatric prescribing.
• To identify vulnerable pediatric populations susceptible to medication errors.
• To emphasize the role of clinical pharmacists in ensuring safe and rational pediatric pharmacotherapy.

Main Methods:

• Review of existing literature on pediatric medication errors.
• Analysis of factors contributing to dosing inaccuracies in pediatric patients.
• Examination of the impact of maturational changes on drug disposition and response.

Main Results:

• Approximately 10-15% of pediatric prescriptions involve medication errors.
• Incorrect drug dosing accounts for nearly half of all pediatric medication errors.
• Vulnerable groups include neonates, infants, and obese children requiring specialized dosing considerations.

Conclusions:

• Medication errors, especially dosing errors, are a significant concern in pediatric care.
• Understanding pediatric pharmacokinetic and pharmacodynamic variations is essential for safe prescribing.
• Clinical pharmacist involvement in pediatric pharmacotherapy verification is vital for mitigating risks and ensuring optimal patient outcomes.